HealthTronics (HTRN) and Endocare (ENDO) to Merge
More News related to ENDO
- HealthTronics (HTRN) and Endocare (ENDO) to Merge
- Notable Mergers and Acquisitions of the Day 11/11: CHK/STO, ELRN/ENDO, AFFX
- Elron Group Company Galil Medical Signs Definitive Merger Agreement with Endocare (ENDO)
- Notable Mergers and Acquisitions of the Day 9/12: LEH/BAC, HTRN/ENDO, QSFT
- HealthTronics (HTRN) Withdraws Offer for Endocare (ENDO)
More News related to HTRN
- HealthTronics (HTRN) Tops Q3 EPS by 3c
- HealthTronics, Inc. Announces Third Quarter Results, Positive Contribution From Endocare; Richard Rusk Appointed Chief Financial Officer
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- HealthTronics Third Quarter Conference Call to Take Place On November 5, 2009
- HealthTronics (HTRN) Misses Q2 View By A Penny
More News related to Mergers and Acquisitions
- DOJ Says ORLC/JAVA Merger is Unlikely to be Anti-competitive
- Kraft (KFT) to Ask Holders to Vote to Issue New Shares
- CF Industries (CF) Sends Letter to Terra (TRA) Stockholders
- East West Bancorp (EWBC) Shares Rocket Higher Amid Acqusition of UCB
- Google (GOOG) Agrees to Acquire AdMob for $750M in Stock
HealthTronics, Inc. (Nasdaq: HTRN) and Endocare, Inc. (Nasdaq: ENDO) have entered into a definitive merger agreement that has been unanimously approved by the boards of directors of each company.
Under the terms of the new merger agreement, HealthTronics has agreed to acquire all of the outstanding shares of Endocare common stock pursuant to an exchange offer in which Endocare stockholders can elect to receive for each Endocare share $1.35 per share in cash, provided that the cash consideration does not exceed 50% of the total consideration, or 0.7764 shares of HeathTronics' stock, provided that the stock consideration does not exceed 75% of the total consideration.
Shares of Endocare closed at $0.90 per share on Friday.
Related Categories
Mergers and AcquisitionsStocks Mentioned
+0.00
-0.04Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
